Company Releases

Randox & MD One Launch Accelerator – Randox for Builders

MD One Ventures, Europe’s first Defence and National Security Venture Capital team and Randox, a global diagnostics and healthcare company …

Randox Receives CE Marking for the World’s First Genetic Type 1 Diabetes Risk Test

A global breakthrough enabling early detection, faster access to emerging therapies, and the foundation for the future of Type 1 …

FDA approves the Randox ConcizuTrace™ ELISA Companion Diagnostic (CDx)

Randox Laboratories announced that the U.S. Food and Drug Administration (FDA) has approved the De Novo application for the company’s …

NATROX Wound Care® Symposium

Exploring Patient-Centered Benefits: The Value of Continuous Topical Oxygen Therapy (cTOT) Wednesday 26 May at 4:00 p.m. Room #122 Speakers: Dr Windy Cole …

Inotec AMD Appoints Gordie Nye as Chairman of the Board

Inotec AMD, the leading innovator in continuous topical oxygen therapy (cTOT) for advanced wound care and parent company of NATROX® …